The Effects of 12-Week High-intensity Interval Training With Mindfulness-based Recovery on Executive Function, Fitness, and Mindfulness in Children

February 13, 2024 updated by: Shih-Chun Kao, Purdue University

Supporting High-intensity Interval Training With Mindfulness for Enhancing Childhood Executive Function

The goal of this randomized controlled trial is to learn about the effect of a 12-week school-based intervention combining mindfulness with high-intensity interval training (MF-HIIT), MF-only intervention, and HIIT-only intervention in relative to sedentary activities on executive function (EF) in 10-12 years old children. The main question it aims to answer is whether a 12-week school-based MF-HIIT intervention has larger beneficial effect on EF performance than that following a 12-week school-based MF-only and HIIT-only in relative to the sedentary activities.

Multiple cohorts of participants will be recruited to participate this one-semester study, including the pretest, intervention, and posttest phases.

During the pretest phase, participants an their parents will complete the following

  1. Kaufman Brief Intelligence Test (KBIT) to assess intelligence quotient
  2. Fitnessgram test to assess aerobic capacity, muscle endurance, flexibility, and body mass index
  3. Child and Adolescent Mindfulness Measure (CAMM) questionnaire to assess dispositional mindfulness
  4. Computerized tasks to assess EF
  5. Parent-reported demographic and health information

Following the pretest phase, participants will receive the 12-week classroom-based intervention, with the classroom as the intervention unit.

Following the intervention and during the posttest phase, participants will complete the fitness, measures, EF measures, and dispositional mindfulness measure again.

Researcher will compare the EFn outcome measures following the MF-HIIT, MF-only, and HIIT-only interventions with the sedentary activity intervention to see if MF and HIIT has beneficial effects on children's EF.

Further, researcher will compare the EF measures following the MF-HIIT compared with MF-only and HIIT-only interventions to see if combining MF with HIIT has greater beneficial effects on children's EF than MF and HIIT alone.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

352

Phase

  • Phase 2
  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Shih-Chun (Alvin) Kao, PhD
  • Phone Number: 765-496-2213
  • Email: kao28@purdue.edu

Study Locations

    • Indiana
      • West Lafayette, Indiana, United States, 47907
        • Purdue University
        • Contact:
          • Shih-Chun (Alvin) Kao

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age between 10-12 years old
  • Intelligence Quotient ≥ 85
  • Capable of performing exercise based on pre-participation health screening
  • No formal diagnosis of cognitive disorders (e.g., attention deficit hyperactivity disorder) and neurological diseases (e.g., epilepsy)

Exclusion Criteria:

  • Age outside of the range of 10-12 years old
  • Intelligence Quotient < 85
  • No capable of performing exercise based on pre-participation health screening
  • Has formal diagnosis of cognitive disorders (e.g., attention deficit hyperactivity disorder) and neurological diseases (e.g., epilepsy)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 12-Week Mindful High-Intensity Interval Training (MF-HIIT)
Two 10-min MF-HIIT sessions every school day during the 12-week intervention period. One session in the morning and one session in the afternoon.
Active Comparator: 12-Week High-Intensity Interval Training (HIIT-only)
Two 10-min HIIT-only sessions every school day during the 12-week intervention period. One session in the morning and one session in the afternoon.
Active Comparator: 12-Week Mindfulness (MF-only)
Two 10-min MF-only sessions every school day during the 12-week intervention period. One session in the morning and one session in the afternoon.
Placebo Comparator: 12-Week Sedentary Activities
Two 10-min sedentary sessions every school day during the 12-week intervention period. One session in the morning and one session in the afternoon.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inhibition speed
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
Inhibition speed will be assessed by the response time (ms) during a child-friendly flanker task.
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
Updating speed
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
Updating speed will be assessed by the response time (ms) during a child-friendly n-back task.
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
Shifting speed
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
Shifting speed will be assessed by the response time (ms) during a child-friendly switching task.
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
Inhibition accuracy
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
Inhibition accuracy will be assessed by the response accuracy (percent) during a child-friendly flanker task.
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
Updating accuracy
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
Updating accuracy will be assessed by the response accuracy (percent) during a child-friendly n-back task.
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
Shifting accuracy
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
Shifting accuracy will be assessed by the response accuracy (percent) during a child-friendly switching task.
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Aerobic capacity
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
Aerobic capacity will be assessed by the Progressive Aerobic Cardiovascular Endurance Run (PACER) test
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
Upper body muscle endurance
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
Upper body muscle endurance will be assessed by the push-ups test
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
Core body muscle endurance
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
Core body muscle endurance will be assessed by the curl-ups test
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
Flexibility
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
Flexibility will be assessed by the back-saver sit and reach test
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
Body composition
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
body composition will be assessed by the body mass index computed as weight (kg) / (height [m] * height [m])
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
Dispositional mindfulness
Time Frame: At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends
Dispositional mindfulness will be assessed by the Child and Adolescent Mindfulness Measure questionnaire (CAMM). The questionnaire has 10 items and requires the respondents to rating each item using a 5-point likert scale from 0 (Never True) to 4 (Always True). Higher summed scores indicate higher levels of mindfulness
At the baseline (1-2 weeks) before intervention starts and after (1-2 weeks) the intervention ends

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2024

Primary Completion (Estimated)

May 31, 2026

Study Completion (Estimated)

May 31, 2026

Study Registration Dates

First Submitted

February 6, 2024

First Submitted That Met QC Criteria

February 6, 2024

First Posted (Actual)

February 14, 2024

Study Record Updates

Last Update Posted (Actual)

February 15, 2024

Last Update Submitted That Met QC Criteria

February 13, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • IRB-2023-1683

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Volunteers

Clinical Trials on MF-HIIT

3
Subscribe